Prolonged Administration of Pyridostigmine Impairs Neuromuscular Function with and without Down-regulation of Acetylcholine Receptors

Author:

Richtsfeld Martina1,Yasuhara Shingo1,Fink Heidrun1,Blobner Manfred1,Martyn J. A. Jeevendra1

Affiliation:

1. Research Fellow at Harvard Medical School, Massachusetts General Hospital and Shriners Hospitals for Children, Boston, Massachusetts. Former position: Resident in Anesthesiology, Technische Universität Műnchen, Munich, Germany. Current position: Resident in Anesthesiology, University of Minnesota, Minneapolis, Minnesota. Assistant Professor, Harvard Medical School; Assistant Biochemist, Massachus

Abstract

Abstract Background: The acetylcholinesterase inhibitor, pyridostigmine, is prophylactically administered to mitigate the toxic effects of nerve gas poisoning. The authors tested the hypothesis that prolonged pyridostigmine administration can lead to neuromuscular dysfunction and even down-regulation of acetylcholine receptors. Methods: Pyridostigmine (5 or 25 mg·kg−1·day−1) or saline was continuously administered via osmotic pumps to rats, and infused for either 14 or 28 days until the day of neuromuscular assessment (at day 14 or 28), or discontinued 24 h before neuromuscular assessment. Neurotransmission and muscle function were examined by single-twitch, train-of-four stimulation and 100-Hz tetanic stimulation. Sensitivity to atracurium and acetylcholine receptor number (quantitated by 125I-α-bungarotoxin) provided additional measures of neuromuscular integrity. Results: Specific tetanic tensions (Newton [N]/muscle weight [g]) were significantly (P < 0.05) decreased at 14 (10.3 N/g) and 28 (11.1 N/g) days of 25 mg·kg−1·day−1 pyridostigmine compared with controls (13.1–13.6 N/g). Decreased effective dose (0.81–1.05 vs. 0.16–0.45 mg/kg; P < 0.05) and decreased plasma concentration (3.02–3.27 vs. 0.45–1.37 μg/ml; P < 0.05) of atracurium for 50% paralysis (controls vs. 25 mg·kg−1·day−1 pyridostigmine, respectively), irrespective of discontinuation of pyridostigmine, confirmed the pyridostigmine-induced altered neurotransmission. Pyridostigmine (25 mg·kg−1·day−1) down-regulated acetylcholine receptors at 28 days. Conclusions: Prolonged administration of pyridostigmine (25 mg·kg−1·day−1) leads to neuromuscular impairment, which can persist even when pyridostigmine is discontinued 24 h before assessment of neuromuscular function. Pyridostigmine has the potential to down-regulate acetylcholine receptors, but induces neuromuscular dysfunction even in the absence of receptor changes.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3